KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Inventory (2016 - 2025)

Exact Sciences has reported Inventory over the past 12 years, most recently at $166.2 million for Q4 2025.

  • Quarterly Inventory rose 2.35% to $166.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $166.2 million through Dec 2025, up 2.35% year-over-year, with the annual reading at $166.2 million for FY2025, 2.35% up from the prior year.
  • Inventory was $166.2 million for Q4 2025 at Exact Sciences, up from $164.8 million in the prior quarter.
  • Over five years, Inventory peaked at $176.6 million in Q1 2025 and troughed at $89.0 million in Q1 2021.
  • The 5-year median for Inventory is $127.4 million (2023), against an average of $129.5 million.
  • Year-over-year, Inventory fell 2.6% in 2024 and then skyrocketed 37.38% in 2025.
  • A 5-year view of Inventory shows it stood at $105.0 million in 2021, then increased by 12.63% to $118.3 million in 2022, then rose by 7.79% to $127.5 million in 2023, then increased by 27.38% to $162.4 million in 2024, then grew by 2.35% to $166.2 million in 2025.
  • Per Business Quant, the three most recent readings for EXAS's Inventory are $166.2 million (Q4 2025), $164.8 million (Q3 2025), and $171.5 million (Q2 2025).